Fetal nasal bone assessment in first trimester down syndrome screening

Fetal Diagnosis and Therapy

Volumn 24, Issue 1, 2008, Pages 61-66

  Has, Recep ^a,b   Kalelioglu, Ibrahim ^a   Yuksel, Atil ^a   Ibrahimoglu, Lemi ^a   Ermis, Hayri ^a   Yildirim, Alkan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

First trimester; Nasal bone; Screening; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ARTICLE; BONE MALFORMATION; CHEMICAL ANALYSIS; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; MAXIMUM LIKELIHOOD METHOD; MUSCULOSKELETAL DIAGNOSIS; MUSCULOSKELETAL SYSTEM EXAMINATION; NASAL BONE; NASAL BONE AGENESIS; NOSE MALFORMATION; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 21;

ADULT; CROWN-RUMP LENGTH; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; LIKELIHOOD FUNCTIONS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 47549086908     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000132409     Document Type: Article

References (23)

1. Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH: Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11- to 14-week scan. Ultrasound Obstet Gynecol 2004;23:218-223.
2. Bekker MN, Twisk JW, van Vugt JM: Reproducibility of the fetal nasal bone length measurement. J Ultrasound Med 2004;23:1613-1618.
3. Senat MV, Bernard JP, Boulvain M, Ville Y: Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2003;22:138-141.
4. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH: Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003;23:306-310.
5. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K: Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001;358:1665-1667.
6. Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH: Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006;195:109-114.
7. Otano L, Aiello H, Igarzabal L, Matayoshi T, Gadow EC: Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome. Prenat Diagn 2002;22:930-932.
8. Viora E, Masturzo B, Errante G, Sciarrone A, Bastonero S, Campogrande M: Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses. Prenat Diagn 2003;23:784-787.
9. Ramos-Corpas D, Santiago JC, Montoya F: Ultrasonographic evaluation of fetal nasal bone in a low-risk population at 11-13 + 6 gestational weeks. Prenat Diagn 2006;26:112-117.
10. Collado F, Bombard A, Li V, Julliard K, Aptekar L, Weiner Z: Ethnic variation of fetal nasal bone length between 11-14 weeks' gestation. Prenat Diagn 2005;25:690-692.
11. Zoppi MA, Ibba RM, Axiana C, Floris M, Manca F, Monni G: Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies. Prenat Diagn 2003;23:496-500.
12. Orlandi F, Rossi C, Orlandi E, Jakil MC, Hallahan TW, Macri VJ, Krantz DA: First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone. Am J Obstet Gynecol 2005;192:1107-1111.
13. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade G, Berkowitz RL, Dugoff L, Craigo SD, Carr SR, Wolfe HM, Tripp T, D'Alton ME: First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 2004;104:1222-1228.
14. Bronshtein M, Blazer S, Zimmer EZ: Transvaginal sonographic examination of the fetal nasal bone is unable to predict Down syndrome at 14-16 weeks' gestation. Ultrasound Obstet Gynecol 2005;25:625-627.
15. Has R, Kalelioglu I, Ermis H, Ibrahimoglu L, Yuksel A, Yildirim A, Basaran S: Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester. Fetal Diagn Ther 2006;21:355-359.
16. Prefumo F, Sairam S, Bhide A, Thilaganathan B: First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations. Am J Obstet Gynecol 2006;194:828-833.
17. Stempfle N, Huten Y, Fredouille C, Brisse H, Nessmann C: Skeletal abnormalities in fetuses with Down's syndrome: a radiographic post-mortem study. Pediatr Radiol 1999;29:682-688.
18. Tuxen A, Keeling JW, Reintoft I, Fischer Hansen B, Nolting D, Kjær I: A histological and radiological investigation of the nasal bone in fetuses with Down syndrome. Ultrasound Obstet Gynecol 2003;22:22-26.
19. Minderer S, Gloning KP, Henrich W, Stoger H: The nasal bone in fetuses with trisomy 21: sonographic versus pathomorphological findings. Ultrasound Obstet Gynecol 2003;22:16-21.
20. Larose C, Massoc P, Hillion Y, Bernard JP, Ville Y: Comparison of fetal nasal bone assessment by ultrasound at 11-14 weeks and by postmortem X-ray in trisomy 21: a prospective observational study. Ultrasound Obstet Gynecol 2003;22:27-30.
21. Ville Y: What is the role of fetal nasal bone examination in the assessment of risk for trisomy 21 in clinical practice? Am J Obstet Gynecol 2006;195:1-3.
22. DeVore GR, Romero R: Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results. J Ultrasound Med 2003;22:1191-1199.
23. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O: Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-226.